Akoya Biosciences Inc
General ticker "AKYA" information:
- Sector: Health Care
- Industry: Life Sciences Tools & Services
- Capitalization: $113.4M
Akoya Biosciences Inc does not follow the US Stock Market performance with the rate: -21.9%.
Estimated limits based on current volatility of 3.2%: low 2.30$, high 2.51$
Factors to consider:
- North America accounted for 60.3% of revenue in the fiscal year ended 2023-12-31
- Current price 18.7% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.96$, 6.97$]
- 2024-12-30 to 2025-12-30 estimated range: [3.06$, 7.08$]
Financial Metrics affecting the AKYA estimates:
- Negative: Non-GAAP EPS, $ of -1.48 <= 0.10
- Negative: Operating profit margin, % of -37.37 <= 1.03
- Negative: Operating cash flow per share per price, % of -20.06 <= 2.35
- Negative: negative Net income
- Positive: Investing cash flow per share, $ of 0.08 > -0.12
- Positive: Inventory ratio change, % of 0.50 <= 1.08
Short-term AKYA quotes
Long-term AKYA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $54.92MM | $74.86MM | $96.63MM |
| Operating Expenses | $94.22MM | $140.97MM | $154.30MM |
| Operating Income | $-39.30MM | $-66.11MM | $-57.67MM |
| Non-Operating Income | $-3.78MM | $-4.41MM | $-5.62MM |
| Interest Expense | $3.12MM | $4.55MM | $8.76MM |
| R&D Expense | $15.70MM | $23.21MM | $21.89MM |
| Income(Loss) | $-43.08MM | $-70.52MM | $-63.28MM |
| Taxes | $-0.14MM | $0.12MM | $0.04MM |
| Profit(Loss) | $-42.94MM | $-70.64MM | $-63.32MM |
| Stockholders Equity | $121.35MM | $58.58MM | $53.77MM |
| Inventory | $9.01MM | $14.49MM | $17.88MM |
| Assets | $190.91MM | $176.03MM | $180.37MM |
| Operating Cash Flow | $-36.07MM | $-53.50MM | $-50.90MM |
| Capital expenditure | $5.09MM | $7.36MM | $3.65MM |
| Investing Cash Flow | $-5.09MM | $-14.08MM | $3.35MM |
| Financing Cash Flow | $137.03MM | $28.73MM | $56.84MM |
| Earnings Per Share* | $-1.15 | $-1.87 | $-1.43 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.